Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors

DSpace/Manakin Repository

Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors
 
de Bruin-Weller, M; Graham, N M H; Pirozzi, G; Shumel, B
(2018) British Journal of Dermatology, volume 178, issue 5, pp. 1220 - 1221
(Letter)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Adrenal Cortex Hormones, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Conjunctivitis, Cyclosporine, Dermatitis, Atopic, Freedom, Humans, Interleukin-17, Letter, Comment
DOI: https://doi.org/10.1111/bjd.16348
ISSN: 0007-0963
Publisher: Wiley-Blackwell
Note: Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. (ClinicalTrials.gov Identifier: NCT02755649). Medical writing/editorial assistance provided by Vicki Schwartz, PhD, of Excerpta Medica, funded by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
(Peer reviewed)